Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342806 · ClinicalTrials.gov registry record
Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 51,466
- Enrollment target
NCT04342806: Completed study, sponsored by Duke University.
NCT04342806 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 51,466 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04342806 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 51,466 participants
- Enrollment target
Study Summary
The HERO Registry provides a resource for collecting information on Healthcare Workers (HCWs) currently working in the United States, and their families and communities. The overall goal of the Registry is to develop the infrastructure necessary to create and engage a community of people who may be eligible for participation in future research studies, including those of COVID-19 prophylaxis and treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51,466 participants |
| Start Date | 2020-04-10 |
| Est. Completion | 2022-09-30 |
What the finished NCT04342806 record still lists
NCT04342806 is an observational study that tracks outcomes without assigning an intervention. Its 51,466 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04342806 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04342806 about?
NCT04342806 is a clinical study titled "Healthcare Worker Exposure Response and Outcomes (HERO) Registry Study, COVID-19". The HERO Registry provides a resource for collecting information on Healthcare Workers (HCWs) currently working in the United States, and their families and communities. The overall goal of the Registry is to develop the infrastructure necessary to create and engage a community of people who may be ...
What is the current status of trial NCT04342806?
This trial is currently completed. The enrollment target is 51,466 participants. The study started on 2020-04-10. Estimated completion is 2022-09-30.
Who is sponsoring clinical trial NCT04342806?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06355934 · 52,121 participants
OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
- NCT05975671 · 52,500 participants · NA
Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis
- NCT00500123 · 50,000 participants
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
- NCT01885299 · 50,000 participants
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI